PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21410330-3	2011	To better understand COX-2-independent molecular mechanisms underlying the antitumor activity of celecoxib, we investigated the expression profile of the celecoxib-treated COX-2-positive (Huh7) and COX-2-negative (HepG2) liver cancer cell lines, using microarray analysis.	Celecoxib	154-163	MIR7-3 host gene	Homo sapiens	188-192	
21410330-4	2011	Celecoxib treatment resulted in significantly altered expression levels of 240 and 403 transcripts in Huh7 and HepG2 cells, respectively.	Celecoxib	0-9	MIR7-3 host gene	Homo sapiens	102-106